User: Guest  Login
Title:

A phase III randomized study of neoadjuvant chemotherapy (NAC) alone or in combination with nivolumab (NIVO) +/- linrodostat mesylate, followed by adjuvant postsurgical NIVO +/- linrodostat, in cisplatin-eligible muscle invasive bladder cancer (MIBC).

Document type:
Meeting Abstract
Author(s):
Sonpavde, Guru; Necchi, Andrea; Gupta, Shilpa; Steinberg, Gary D.; Gschwend, Juergen; Van der Heijden, Michiel Simon; Richiero, Audrey; Lambert, Alexandre; Raybold, Bradley; Gajavelli, Srikanth; Zardavas, Dimitrios; Galsky, Matt D.
Journal title abbreviation:
J Clin Oncol
Year:
2020
Journal volume:
38 Suppl S
Journal issue:
15
Print-ISSN:
0732-183X
TUM Institution:
Urologische Klinik und Poliklinik
 BibTeX